OncoTAb's cutting edge patented technology was used to develop a blood test, Agkura™ Personal Score, which aids breast cancer detection in women with dense breast tissue.
MAKING THINGS EASIER FOR WOMEN WITH DENSE BREAST TISSUE
What is Agkura™ Personal Score?
The Agkura™ Personal Score is a simple blood test that measures the level of a tumor protein that increases with cancer. This is effective in testing for breast cancer in women with dense breast tissue. Mammography alone misses 50% of cancers in women with dense breasts.
The staining is so specific with TAB-004, for most cases of mammary carcinoma immunoreactivity in the tumor can be appreciated even without the microscope …. You can just hold the slide up to visualize the strong staining. In contrast, benign lesions show absence of staining. Given this specificity, OncoTAb’s blood test may be a useful supplemental test with mammography for women with dense breast tissue.
The Solution
Chad A. Livasy, MD, Clinical Pathologist
The staining is so specific with TAB-004, for most cases of mammary carcinoma immunoreactivity in the tumor can be appreciated even without the microscope …. You can just hold the slide up to visualize the strong staining. In contrast, benign lesions show absence of staining. Given this specificity, OncoTAb’s blood test may be a useful supplemental test with mammography for women with dense breast tissue.
The Solution
Chad A. Livasy, MD, Clinical Pathologist
The staining is so specific with TAB-004, for most cases of mammary carcinoma immunoreactivity in the tumor can be appreciated even without the microscope …. You can just hold the slide up to visualize the strong staining. In contrast, benign lesions show absence of staining. Given this specificity, OncoTAb’s blood test may be a useful supplemental test with mammography for women with dense breast tissue.
